Simplex Trading
NKTR icon

Simplex Trading’s Nektar Therapeutics NKTR Stock Holding History

Simplex Trading’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32M Sell
32,300
-30,400
-48% -$1.73M ﹤0.01% 1698
2025
Q4 		$2.65M Sell
62,700
-5,900
-9% -$330K ﹤0.01% 1753
2025
Q3 		$3.9M Sell
68,600
-65,000
-49% -$2.15M ﹤0.01% 1692
2025
Q2 		$3.45M Buy
133,600
+133,500
+133,500% +$1.5M ﹤0.01% 1653
2025
Q1 		$1K Sell
100
-987
-91% -$12.9K ﹤0.01% 8256
2024
Q4 		$15K Sell
1,087
-2,180
-67% -$38.4K ﹤0.01% 6900
2024
Q3 		$63K Buy
3,267
+2,754
+537% +$52.5K ﹤0.01% 5684
2024
Q2 		$9K Sell
513
-12,367
-96% -$261K ﹤0.01% 7507
2024
Q1 		$180K Buy
+12,880
New +$135K ﹤0.01% 4977
2023
Q4 		– Sell
-413
Closed -$3K – 9475
2023
Q3 		$3K Buy
413
+93
+29% +$895 ﹤0.01% 7929
2023
Q2 		$2K Buy
320
+80
+33% +$853 ﹤0.01% 8461
2023
Q1 		$2K Sell
240
-320
-57% -$9.68K ﹤0.01% 8489
2022
Q4 		$18K Sell
560
-14,533
-96% -$703K ﹤0.01% 6981
2022
Q3 		$724K Sell
15,093
-1,274
-8% -$75.8K ﹤0.01% 3036
2022
Q2 		$932K Buy
16,367
+9,854
+151% +$622K ﹤0.01% 2697
2022
Q1 		$526K Buy
6,513
+3,313
+104% +$490K ﹤0.01% 3782
2021
Q4 		$648K Buy
3,200
+2,420
+310% +$525K ﹤0.01% 3469
2021
Q3 		$204K Buy
780
+40
+5% +$9.62K ﹤0.01% 5559
2021
Q2 		$190K Buy
740
+721
+3,795% +$200K ﹤0.01% 5762
2021
Q1 		$578K Sell
19
-44
-70% -$13.7K ﹤0.01% 3168
2020
Q4 		$1.6M Buy
63
+42
+200% +$10.9K ﹤0.01% 2001
2020
Q3 		$524K Sell
21
-4
-16% -$1.26K ﹤0.01% 2949
2020
Q2 		$870K Buy
25
+21
+525% +$6.55K ﹤0.01% 2276
2020
Q1 		$96K Sell
4
-47
-92% -$14.5K ﹤0.01% 4411
2019
Q4 		$1.67M Sell
51
-39
-43% -$11.3K ﹤0.01% 1640
2019
Q3 		$2.47M Buy
90
+57
+173% +$20.9K 0.01% 1175
2019
Q2 		$1.74M Sell
33
-1
-3% -$501 ﹤0.01% 1419
2019
Q1 		$1.7M Buy
34
+7
+26% +$4.15K ﹤0.01% 1524
2018
Q4 		$1.32M Buy
27
+10
+59% +$6.04K ﹤0.01% 1406
2018
Q3 		$1.54M Sell
17
-29
-63% -$24.8K 0.01% 1472
2018
Q2 		$3.38M Buy
46
+38
+475% +$43.8K 0.01% 778
2018
Q1 		$411K Sell
8
-25
-76% -$32.2K 0.02% 819
2017
Q4 		$1.5M Buy
33
+24
+267% +$14.2K 0.06% 259
2017
Q3 		$28K Sell
9
-17
-65% -$5.32K ﹤0.01% 2842
2017
Q2 		$22K Sell
26
-17
-40% -$4.91K ﹤0.01% 3217
2017
Q1 		$493K Buy
43
+38
+760% +$8.54K 0.02% 675
2016
Q4 		$5K Buy
5
+1
+25% +$203 ﹤0.01% 4366
2016
Q3 		$4K Sell
4
-3
-43% -$772 ﹤0.01% 4493
2016
Q2 		$3K Buy
7
+6
+600% +$1.34K ﹤0.01% 4664
2016
Q1 		$2K Sell
1
-15
-94% -$2.88K ﹤0.01% 4762
2015
Q4 		$103K Buy
+16
New +$3.29K 0.01% 1333
2015
Q3 		– Sell
-13
Closed -$12K – 5960
2015
Q2 		$12K Buy
13
+8
+160% +$1.38K ﹤0.01% 2917
2015
Q1 		$1K Hold
5
– – ﹤0.01% 4531
2014
Q4 		$13K Buy
+5
New +$1.07K ﹤0.01% 2396

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Simplex Trading's NKTR Position: Q1 2026 in Review

Simplex Trading reduced its Nektar Therapeutics (NKTR) stake by 74% in Q1 2026, selling an estimated $923K and leaving 5,722 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #3501.

Simplex Trading first reported a position in NKTR in Q4 2014 and has held it in 41 quarters since. The position peaked at $4.35M in Q3 2025. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Simplex Trading held 5,722 shares of Nektar Therapeutics worth $412K as of Q1 2026.
  • Simplex Trading sold 16,214 Nektar Therapeutics shares in Q1 2026, an estimated $923K.
  • Nektar Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3501 holding.
  • Simplex Trading first reported a position in Nektar Therapeutics in Q4 2014 and has held it in 41 quarters since.
  • Simplex Trading's Nektar Therapeutics position peaked at $4.35M in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.